April 2022 – Policy & Medicine

Accredited CME Program Reviews Challenges, New Guidelines for Mycobacterium Avium Complex

Study Finds that Laws Meant to Curb Opioid Prescribing Practices Are Not Effective

New Report on Social Drivers of Health and Physician Practice

Kentucky PBM Law in Jeopardy

DOJ Files False Claims Act Complaint Against CEOs and Entities

FDA Requests Comments on Potential Modification to Opioid Analgesic Risk Evaluation and Mitigation Strategy

Policy and Medicine Compliance Update April 2022 Issue Offers Insight into Digital Enforcement, Trends in False Claims Settlements and Warning on Sole Reliance on Fair Market Value

Agencies Issue Report on Mental Health Parity and Addiction Equity Act

Kaiser Family Foundation Report Finds Drug Prices Increased Faster than Inflation

FDA Publishes Guidance on Premarket Pathways for Combination Products